c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
SELLAS Life Sciences (SLS) Surges 200% Premarket on Positive Phase 3 REGAL Trial Results
GuruFocus | Nov 17, 2026 9:56 AM EST
Related Stocks: SLS ,
Read original article